BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1892223)

  • 1. Vascular alterations in Fukuyama type congenital muscular dystrophy.
    Sugino S; Miyatake M; Ohtani Y; Yoshioka K; Miike T; Uchino M
    Brain Dev; 1991; 13(2):77-81. PubMed ID: 1892223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial cell injury and platelet embolism in Duchenne muscular dystrophy at the preclinical stage.
    Miike T; Sugino S; Ohtani Y; Taku K; Yoshioka K
    J Neurol Sci; 1987 Dec; 82(1-3):67-80. PubMed ID: 3440873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical analysis of dystrophin in congenital muscular dystrophy.
    Arikawa E; Ishihara T; Nonaka I; Sugita H; Arahata K
    J Neurol Sci; 1991 Sep; 105(1):79-87. PubMed ID: 1795174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies.
    Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H
    Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal localization of laminin subunits in muscular dystrophies.
    Hayashi YK; Engvall E; Arikawa-Hirasawa E; Goto K; Koga R; Nonaka I; Sugita H; Arahata K
    J Neurol Sci; 1993 Oct; 119(1):53-64. PubMed ID: 8246011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An electron microscopical study of the T-system in biopsied muscles from Fukuyama type congenital muscular dystrophy.
    Miike T; Ohtani Y; Tamari H; Ishitsu T; Nonaka I
    Muscle Nerve; 1984 Oct; 7(8):629-35. PubMed ID: 6543909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial alterations of skeletal muscle capillaries in childhood myopathies.
    Kobayashi Y; Suzuki H; Iinuma K; Tada K; Yamamoto TY
    Tohoku J Exp Med; 1983 Aug; 140(4):381-9. PubMed ID: 6636137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Japanese family with two types of muscular dystrophy: DNA analysis and the dystrophin test.
    Matsumura K; Toda T; Hasegawa T; Kamei M; Imoto N; Shimizu T
    J Child Neurol; 1991 Jul; 6(3):251-6. PubMed ID: 1875028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light and electron microscopic studies of congenital muscular dystrophy.
    Misugi N
    Brain Dev; 1980; 2(2):191-9. PubMed ID: 7435878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy.
    Ishii H; Hayashi YK; Nonaka I; Arahata K
    Neuromuscul Disord; 1997 May; 7(3):191-7. PubMed ID: 9185184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle regeneration and satellite cells in Fukuyama type congenital muscular dystrophy.
    Terasawa K
    Muscle Nerve; 1986 Jun; 9(5):465-70. PubMed ID: 3724791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breached cerebral glia limitans-basal lamina complex in Fukuyama-type congenital muscular dystrophy.
    Saito Y; Murayama S; Kawai M; Nakano I
    Acta Neuropathol; 1999 Oct; 98(4):330-6. PubMed ID: 10502035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital muscular dystrophy. A histochemical study with morphometric analysis on biopsied muscles.
    Kihira S; Nonaka I
    J Neurol Sci; 1985 Sep; 70(2):139-49. PubMed ID: 4056819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered aquaporin 4 expression in muscles of Fukuyama-type congenital muscular dystrophy.
    Wakayama Y; Jimi T; Inoue M; Kojima H; Yamashita S; Kumagai T; Murahashi M; Hara H; Shibuya S
    Virchows Arch; 2003 Dec; 443(6):761-7. PubMed ID: 12942324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital muscular dystrophy in Marinesco-Sjögren syndrome.
    Tachi N; Nagata N; Wakai S; Chiba S
    Pediatr Neurol; 1991; 7(4):296-8. PubMed ID: 1930423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital muscular dystrophy with characteristic radiological findings similar to those with Fukuyama congenital muscular dystrophy.
    Garg A; Gulati S; Gupta V; Kalra V
    Neurol India; 2004 Dec; 52(4):496-8. PubMed ID: 15626844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbindin, syncoilin, and beta-synemin mRNA levels in dystrophic muscles.
    Wakayama Y; Matsuzaki Y; Yamashita S; Inoue M; Jimi T; Hara H; Unaki A; Iijima S; Masaki H
    Int J Neurosci; 2010 Feb; 120(2):144-9. PubMed ID: 20199207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy.
    Matsumura K; Nonaka I; Campbell KP
    Lancet; 1993 Feb; 341(8844):521-2. PubMed ID: 8094772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of sarcospan in muscles of Fukuyama congenital muscular dystrophy.
    Wakayama Y; Inoue M; Kojima H; Yamashita S; Shibuya S; Jimi T; Hara H; Matsuzaki Y; Oniki H; Kanagawa M; Kobayashi K; Toda T
    Histol Histopathol; 2008 Dec; 23(12):1425-38. PubMed ID: 18830929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.